Highest-materiality recent filing
Omega Flex Q2 2026 net income down 35.6% YoY; CE Mark for MediTrac
Net sales Q2 2026 $24.057M, down 5.8% YoY; six-month net sales $47.15M, down 3.5%.
Omega Flex Q1 2026 net income falls 41.8% to $2.08M; sales down 1%
Net sales $23.1M for Q1 ended March 31, 2026, down 1.0% from $23.3M a year ago.
Omega Flex FY2025 net sales $98.3M (-3.3%), net income $14.8M (-17.7%)
FY2025 net sales $98.3M vs $101.7M in 2024, down 3.3%; Q4 net sales $25.2M, down 6.5% YoY.
Omega Flex Q3 net sales fall 2.6% YoY; net income down 20.1%
Q3 2025 net sales $24.23M vs $24.88M YoY; net income $3.69M vs $4.62M.
Omega Flex Q2 net income down 7.6% to $4.16M; housing starts drag
Q2 2025 net sales $25.525M (+3.7% YoY); net income $4.156M (-7.6% YoY).
Omega Flex Q1 net income falls 15.4% to $3.6M; sales down 7.5% on lower housing starts
Net sales of $23.33M, down 7.5% from $25.22M in Q1 2024.
Omega Flex Q4 2024 net sales down 4.2% YoY; full-year EPS $1.78 vs $2.06
Net sales $101.7M in 2024, down 8.8% from $111.5M in 2023.
Omega Flex Q3 net sales down 9.5%; EPS $0.46 vs $0.55, net income falls 17.2%
Nine-month net sales $74.7M, down 10.3% YoY; Q3 net sales $24.9M, down 9.5%.
Omega Flex reports 10.7% sales decline in H1 2024; net income down 15.4%
Net sales for six months $49.8M, down 10.7% YoY; Q2 sales $24.6M, down 4.7%.
Omega Flex Q1 net sales down 15.9% to $25.2M; EPS falls to $0.42
Net sales $25.2M, down 15.9% YoY; net income $4.2M, down 26.5%.
Omega Flex reports FY2023 revenue down 11.2%; EPS falls to $2.06 from $2.34
Net sales $111.5M for FY2023, down 11.2% vs $125.5M in FY2022.
Omega Flex Q3 net sales down 13.1% YoY; EPS $0.55 vs $0.65
9-month net sales $83.3M, down 12.0% YoY; Q3 net sales $27.5M, down 13.1%.
Omega Flex Q2 net sales down 18.6% YoY; EPS $0.45 vs $0.54
Q2 2023 net sales $25.8M, down 18.6% from $31.7M; net income $4.6M ($0.45 EPS) vs $5.5M ($0.54 EPS) YoY.
Omega Flex Q1 net income up 5.3% to $5.74M, sales down 4.2% to $29.99M
EPS $0.57 vs $0.54 YoY; net income $5.74M vs $5.45M.
Omega Flex reports FY2022 net sales down 3.5% to $125.5M; net income down 9.8% to $23.6M
Net sales $125.5M for FY2022 vs $130.0M in 2021, down 3.5%; Q4 net sales $30.8M vs $35.5M, down 13.1%.
Omega Flex Q2 net income down 11.9% to $5.45M, EPS $0.54 vs $0.61
Q2 net sales $31.75M, down 0.7% YoY; six-month sales $63.04M, up 0.3%.
Omega Flex Q1 net income down 13% to $5.45M; EPS $0.54 vs $0.62 YoY
Net sales $31.3M, up 1.4% YoY from $30.9M.
Omega Flex reports record FY2021: Net sales $130M (+22.9%), net income $26.2M (+31.6%), EPS $2.60
Full-year net sales $130.0M vs $105.8M in FY2020; net income $26.2M vs $19.9M.
the Board of Directors of Omega Flex, Inc. (the “Company”) unanimously elected Stephen M. Shea as a Class 2 Director of the Company, with a term expiring at the 2025 annual meeting of shareholders.
On April 4, 2024, Derek W. Glanvill, a director of Omega Flex, Inc. (the “Company”), informed the Company of his resignation from the board of directors of the Company, effective immediately.
Kevin R. Hoben will be Executive Chairman of the Company
Susan B. Asch will be promoted to be a Vice President of the Company, in addition to serving as its General Counsel and Corporate Secretary
Edwin B. Moran will replace Mr. Rivest as President of the Company
and Dean W. Rivest as a Class 3 Director of the Company
unanimously elected Edwin B. Moran as a Class 2 Director of the Company
David R. Edler will be promoted from Director - MediTrac, to Vice President and General Manager - MediTrac
Dean W. Rivest will replace Mr. Hoben as Chief Executive Officer of the Company
On September 26, 2023, Mark F. Albino, a director of Omega Flex, Inc. (the “Company”), informed the Company of his resignation from the board of directors (the “Board”) of the Company, effective September 30, 2023.
On May 31, 2022, Omega Flex, Inc. (the “Company”) announced that Mark F. Albino, the Company’s chief operating officer, is retiring from his executive role effective immediately.
On April 5, 2022, Bruce C. Klink, a director of the Company, informed the Board of Directors (the “Board”) of Omega Flex, Inc. (the “Company”) that he has elected to not stand for re-election and will complete his term on the Board at the conclusion of the Company’s 2022 annual meeting of stockholders.
Max materiality 0.75 · Median 0.50 · Most common event earnings